When BCR::ABL1 transcript levels are investigated by qRT-PCR in paired PB and BM specimens, a good overall concordance of BCR::ABL1 (IS) results is generally found, thus supporting the current practice to primarily use PB for long-term molecular follow-up monitoring in CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.